Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can disposable surgical tools make hip replacement cheaper and safer?

NCT ID NCT04903860

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This trial compares two types of surgical tools used during total hip replacement: single-use (disposable) reaming instruments and conventional reusable ones. The main focus is on the overall cost of surgery, including sterilization, materials, and operating room time. Researchers will also track surgical time and patient recovery scores. The study involves 40 adults undergoing their first hip replacement due to arthritis.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
single-use ancillary reaming material
What this could lead to
If single-use tools prove cost-effective and safe, they could become a standard option for hip replacement surgery, potentially reducing infection risks and streamlining hospital logistics.
What could go wrong
The trial is small and early, so results may not apply broadly. Single-use tools might be more expensive or offer no clear benefit over reusable ones.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Jul 2021

Finished

Jul 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * \- Patient, male or female, over 18 years of age, eligible for a first-line total hip replacement for isolated coxarthrosis * Patient registered to the national health system * Patient able to understand information about the protocol and answer to questionnaire Exclusion Criteria: * Pregnant, breastfeeding or potentially pregnant woman * Major disability * History of hip replacement surgery * Any surgical and/or anesthetic contraindication, or any condition deemed by the investigator to be incompatible with the research. * Morbid obesity as defined by body mass index (BMI) \>40 kg.m-2 * History of recent infection at the surgical site * Surgical contraindication * Refusal to participate

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coxarthrosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU clermont-ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.